Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] ALL
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6300 6301 6302 6303 6304 6305 6306 6307 6308 6309 6310 6311 6312 6313 6314 6315 6316 6317 6318 6319 6320 6321 6322 6323 6324 6325 6326 6327 6328 6329 6330 6331 6332 6333 6334 6335 6336 6337 6338 6339 6340 … 6459 6460 6461 6462 6463 6464 6465 6466 6467 6468 6469 6470 6471 6472 6473 6474 6475 6476 6477 6478 Next Last
#
NCTID/Status
Study
Last Changed
315951
NCT00065117
Terminated
Terminated
Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.
Conditions: Colorectal Neoplasms; Metastases, Neoplasm
Intervention: ZD6126, Placebo, 5-fluorouracil, Leucovorin, Oxaliplatin
Conditions: Colorectal Neoplasms; Metastases, Neoplasm
Intervention: ZD6126, Placebo, 5-fluorouracil, Leucovorin, Oxaliplatin
January 25, 2011
315952
NCT00065104
Completed
Completed
August 16, 2006
315953
NCT00065078
Unknown status
Unknown status
Providing Birth Control Through Home Health Visits
Conditions: Pregnancy
Intervention: Home Dispensing Of Contraception
Conditions: Pregnancy
Intervention: Home Dispensing Of Contraception
September 9, 2005
315954
NCT00065065
Completed
Completed
A Trial of Rosiglitazone for Ulcerative Colitis
Conditions: Ulcerative Colitis; Inflammatory Bowel Disease
Intervention: Rosiglitazone, Placebo
Conditions: Ulcerative Colitis; Inflammatory Bowel Disease
Intervention: Rosiglitazone, Placebo
December 14, 2017
315955
NCT00065052
Completed
Completed
Modifying the Home Television Watching Environment
Conditions: Obesity; Body Weight Changes
Intervention: Behavior Modification
Conditions: Obesity; Body Weight Changes
Intervention: Behavior Modification
January 12, 2010
315956
NCT00065039
Completed
Completed
Wise Mind: Environmental Approach for Obesity Prevention
Conditions: Healthy
Intervention: Promotion Of A Healthy Diet And Physical Activity, Avoidance Of Alcohol, Drugs, And Tobacco
Conditions: Healthy
Intervention: Promotion Of A Healthy Diet And Physical Activity, Avoidance Of Alcohol, Drugs, And Tobacco
January 12, 2010
315957
NCT00065026
Completed
Completed
Increasing Physical Activity Levels in Low-Income Women
Conditions: Healthy
Intervention: Physical Activity Opportunities For Low-income Women
Conditions: Healthy
Intervention: Physical Activity Opportunities For Low-income Women
January 12, 2010
315958
NCT00065013
Completed
Completed
Strength Training Following Gastric Bypass for Obesity
Conditions: Obesity
Intervention: Strength Training
Conditions: Obesity
Intervention: Strength Training
June 23, 2010
315959
NCT00065000
Completed
Completed
Impact of Non-Commercialism Policy in Seattle Schools
Conditions: Obesity
Intervention: Water, Cafeteria And Staff Health Promotion
Conditions: Obesity
Intervention: Water, Cafeteria And Staff Health Promotion
January 12, 2010
315960
NCT00004204
Unknown status
Unknown status
Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
Conditions: Brain and Central Nervous System Tumors
Intervention: Temozolomide
Conditions: Brain and Central Nervous System Tumors
Intervention: Temozolomide
January 3, 2014
315961
NCT00004006
Completed
Completed
Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma
Conditions: Retinoblastoma
Intervention: Filgrastim, Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Topotecan Hydrochloride, Autologous Bone Marrow Transplantation, Radiation Therapy
Conditions: Retinoblastoma
Intervention: Filgrastim, Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Topotecan Hydrochloride, Autologous Bone Marrow Transplantation, Radiation Therapy
October 3, 2011
315962
NCT00003895
Completed
Completed
Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma
Conditions: Recurrent Melanoma; Stage IA Melanoma; Stage IB Melanoma; Stage IIA Melanoma; Stage IIB Melanoma; Stage IIC Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma
Intervention: HPV 16 E7:12-20, Gp100:209-217(210M), Laboratory Biomarker Analysis
Conditions: Recurrent Melanoma; Stage IA Melanoma; Stage IB Melanoma; Stage IIA Melanoma; Stage IIB Melanoma; Stage IIC Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma
Intervention: HPV 16 E7:12-20, Gp100:209-217(210M), Laboratory Biomarker Analysis
December 28, 2016
315963
NCT00003795
Completed
Completed
Quality of Life in Survivors of Gynecologic Cancer
Conditions: Endometrial Cancer; Ovarian Cancer
Intervention: Quality-of-life Assessment
Conditions: Endometrial Cancer; Ovarian Cancer
Intervention: Quality-of-life Assessment
May 24, 2013
315964
NCT00003759
Completed
Completed
AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer
Conditions: Bladder Cancer
Intervention: BCG Vaccine, Valrubicin, Conventional Surgery
Conditions: Bladder Cancer
Intervention: BCG Vaccine, Valrubicin, Conventional Surgery
January 30, 2013
315965
NCT00064987
Terminated
Terminated
Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism
Conditions: Hypogonadism; Kallmann Syndrome
Intervention: Testicular Biopsy, Gonadotropin Releasing Hormone (GnRH), Follicle Stimulating Hormone (FSH)
Conditions: Hypogonadism; Kallmann Syndrome
Intervention: Testicular Biopsy, Gonadotropin Releasing Hormone (GnRH), Follicle Stimulating Hormone (FSH)
July 5, 2017
315966
NCT00064974
Completed
Completed
Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes
April 3, 2013
315967
NCT00064961
Completed
Completed
Obesity Prevention After Smoking Cessation in Menopause
Conditions: Obesity; Menopause
Conditions: Obesity; Menopause
December 9, 2009
315968
NCT00064935
Completed
Completed
June 23, 2005
315969
NCT00064922
Completed
Completed
Incentive Programs for Female Substance Abusers Who Smoke - 3
Conditions: Tobacco Use Disorder
Intervention: Behavior Therapy
Conditions: Tobacco Use Disorder
Intervention: Behavior Therapy
January 11, 2017
315970
NCT00064870
Recruiting
Recruiting
Alzheimer's Disease Genetics Study
Conditions: Alzheimer Disease; Late Onset Alzheimer Disease; Dementia
Conditions: Alzheimer Disease; Late Onset Alzheimer Disease; Dementia
February 27, 2019
315971
NCT00064857
Completed
Completed
Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors
Conditions: Lymphedema; Breast; Cancer
Intervention: Pycnogenol
Conditions: Lymphedema; Breast; Cancer
Intervention: Pycnogenol
April 21, 2008
315972
NCT00064909
Completed
Completed
MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis
Conditions: Multiple Sclerosis
Conditions: Multiple Sclerosis
March 3, 2008
315973
NCT00064896
Completed
Completed
Technical Development of Cardiovascular Magnetic Resonance Imaging
Conditions: Peripheral Artery Disease
Intervention: MRI
Conditions: Peripheral Artery Disease
Intervention: MRI
October 27, 2017
315974
NCT00064883
Recruiting
Recruiting
Radiation Therapy and the Natural History of Childhood Cancers
Conditions: Cancer; Childhood Malignancy
Conditions: Cancer; Childhood Malignancy
November 27, 2019
315975
NCT00064844
Completed
Completed
Combination Nicotine Replacement for Alcoholic Smokers
Conditions: Smoking; Alcoholism
Intervention: Cognitive Behavior Therapy For Alcohol And Smoking Cessation
Conditions: Smoking; Alcoholism
Intervention: Cognitive Behavior Therapy For Alcohol And Smoking Cessation
March 8, 2013
315976
NCT00064831
Completed
Completed
Black Cohosh Extract in Postmenopausal Breast Health
Conditions: Menopause; Hot Flashes
Conditions: Menopause; Hot Flashes
December 6, 2007
315977
NCT00064818
Completed
Completed
Acupuncture Needling on Connective Tissue by Ultrasound
Conditions: Healthy
Conditions: Healthy
August 17, 2006
315978
NCT00064805
Completed
Completed
Therapy for Reading Problems in Adults After Brain Injury
Conditions: Dyslexia, Acquired; Brain Injuries; Cerebrovascular Accident
Intervention: Cognitive Therapy To Improve Reading
Conditions: Dyslexia, Acquired; Brain Injuries; Cerebrovascular Accident
Intervention: Cognitive Therapy To Improve Reading
August 13, 2014
315979
NCT00064779
Completed
Completed
Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
Conditions: Malignant Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Mixed Oligoastrocytoma
Intervention: IL13-PE38QQR, Targeted Fusion Protein Therapy, Surgery
Conditions: Malignant Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Mixed Oligoastrocytoma
Intervention: IL13-PE38QQR, Targeted Fusion Protein Therapy, Surgery
June 2, 2011
315980
NCT00064766
Unknown status
Unknown status
Norplant and Irregular Bleeding/Spotting
Conditions: Endometrial Bleeding; Periodontal Disease
Intervention: Doxycycline
Conditions: Endometrial Bleeding; Periodontal Disease
Intervention: Doxycycline
June 23, 2005
315981
NCT00064753
Completed
Completed
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Conditions: Chronic Kidney Disease; Cardiovascular Disease; Death
Intervention: High Dose Multivitamin, Low Dose Multivitamin
Conditions: Chronic Kidney Disease; Cardiovascular Disease; Death
Intervention: High Dose Multivitamin, Low Dose Multivitamin
September 17, 2017
315982
NCT00003712
Completed
Completed
CCI-779 in Treating Patients With Advanced Solid Tumors
Conditions: Brain and Central Nervous System Tumors; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Temsirolimus
Conditions: Brain and Central Nervous System Tumors; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Temsirolimus
August 7, 2012
315983
NCT00003707
Completed
Completed
Combination Chemotherapy in Treating Patients With Advanced Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
June 26, 2012
315984
NCT00003645
Completed
Completed
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
Conditions: Prostate Cancer
Intervention: Flutamide, Leuprolide Acetate
Conditions: Prostate Cancer
Intervention: Flutamide, Leuprolide Acetate
March 21, 2017
315985
NCT00003571
Completed
Completed
Gene Testing in Patients With Colon Cancer
Conditions: Colorectal Cancer
Intervention: Mutation Analysis, Tumor Replication Error Analysis
Conditions: Colorectal Cancer
Intervention: Mutation Analysis, Tumor Replication Error Analysis
July 1, 2016
315986
NCT00003382
Terminated
Terminated
Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Intervention: Filgrastim, Gemcitabine Hydrochloride, Topotecan Hydrochloride
Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Intervention: Filgrastim, Gemcitabine Hydrochloride, Topotecan Hydrochloride
June 7, 2013
315987
NCT00064792
Completed
Completed
Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
Conditions: Smith-Lemli-Opitz Syndrome
Intervention: Simvastatin Susp., OraPlus
Conditions: Smith-Lemli-Opitz Syndrome
Intervention: Simvastatin Susp., OraPlus
June 4, 2014
315988
NCT00064740
Completed
Completed
Relaxation Response With Acupuncture for HIV Patients
Conditions: Human Immunodeficiency Virus; AIDS
Intervention: Relaxation Response
Conditions: Human Immunodeficiency Virus; AIDS
Intervention: Relaxation Response
August 16, 2006
315989
NCT00064701
Completed
Completed
Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients
Conditions: Kidney Transplantation
Intervention: Tacrolimus Modified Release (MR), Tacrolimus, Cyclosporine Microemulsion, Mycophenolate Mofetil
Conditions: Kidney Transplantation
Intervention: Tacrolimus Modified Release (MR), Tacrolimus, Cyclosporine Microemulsion, Mycophenolate Mofetil
November 12, 2013
315990
NCT00064688
Withdrawn
Withdrawn
Genomic Dissection of a QTL Affecting the Lipid Profile
Conditions: Cardiovascular Diseases; Heart Diseases; Obesity; Hyperlipidemia, Familial Combined
Conditions: Cardiovascular Diseases; Heart Diseases; Obesity; Hyperlipidemia, Familial Combined
September 8, 2015
315991
NCT00064675
Completed
Completed
Genetics of Cardiovascular Reactivity in Black Youth
Conditions: Cardiovascular Diseases; Heart Diseases; Hypertension
Conditions: Cardiovascular Diseases; Heart Diseases; Hypertension
April 4, 2013
315992
NCT00006073
Terminated
Terminated
Endocrine Studies in Health and Disease
Conditions: Endocrine Diseases
Conditions: Endocrine Diseases
October 5, 2017
315993
NCT00064727
Completed
Completed
Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
Conditions: Congestive Heart Failure
Intervention: Avandia (Rosiglitazone), Avanclia (Rosiqlitazone)
Conditions: Congestive Heart Failure
Intervention: Avandia (Rosiglitazone), Avanclia (Rosiqlitazone)
June 30, 2017
315994
NCT00064714
Completed
Completed
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
Conditions: Diabetes Mellitus
Intervention: AC2993 (exenatide), Daclizumab (immunosuppressive)
Conditions: Diabetes Mellitus
Intervention: AC2993 (exenatide), Daclizumab (immunosuppressive)
February 23, 2015
315995
NCT00064662
Completed
Completed
Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence
Conditions: Urinary Incontinence
Intervention: Burch Modified Tanagho, Autologous Fascia Sling
Conditions: Urinary Incontinence
Intervention: Burch Modified Tanagho, Autologous Fascia Sling
May 8, 2013
315996
NCT00064649
Terminated
Terminated
Minimally Invasive Surgical Therapy for BPH
Conditions: Benign Prostatic Hyperplasia
Intervention: Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA) Therapy, Finasteride And Alfuzosin
Conditions: Benign Prostatic Hyperplasia
Intervention: Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA) Therapy, Finasteride And Alfuzosin
January 12, 2010
315997
NCT00064636
Terminated
Terminated
Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
Conditions: Advanced Non-Small Cell Lung Cancer; Other Solid Tumors
Intervention: VELCADE TM (bortezomib) For Injection, Or PS-341
Conditions: Advanced Non-Small Cell Lung Cancer; Other Solid Tumors
Intervention: VELCADE TM (bortezomib) For Injection, Or PS-341
June 23, 2005
315998
NCT00064623
Completed
Completed
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy
Conditions: HIV Infections; Peripheral Nervous System Diseases; Pain
Intervention: Capsaicin Dermal Patch
Conditions: HIV Infections; Peripheral Nervous System Diseases; Pain
Intervention: Capsaicin Dermal Patch
March 4, 2008
315999
NCT00064610
Completed
Completed
Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer
Conditions: Prostatic Neoplasms
Intervention: VELCADE TM (bortezomib) For Injection
Conditions: Prostatic Neoplasms
Intervention: VELCADE TM (bortezomib) For Injection
February 7, 2008
316000
NCT00064597
Unknown status
Unknown status
Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood
Conditions: Chromosome Disorders
Conditions: Chromosome Disorders
June 23, 2005
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6300 6301 6302 6303 6304 6305 6306 6307 6308 6309 6310 6311 6312 6313 6314 6315 6316 6317 6318 6319 6320 6321 6322 6323 6324 6325 6326 6327 6328 6329 6330 6331 6332 6333 6334 6335 6336 6337 6338 6339 6340 … 6459 6460 6461 6462 6463 6464 6465 6466 6467 6468 6469 6470 6471 6472 6473 6474 6475 6476 6477 6478 Next Last
Last Updated
The last updated date is the most recent date when changes to a clinical trial were
submitted to ClinicalTrials.gov. There is often a delay of a few days before the
updated trial is available on the clinical trials website.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
First Received
The first received date is the date when the clinical trial was first submitted
to ClinicalTrials.gov. There is often a delay of a few days before the
trial is available on the clinical trials website.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Safety Issue
If selected, restricts search results to those studies which have
an outcome measure designated as a safety issue. Note that this is a
poor estimate of the safety of a treatment or intervention, but it is
all we have now.
Funded By
Studies are supported by one or more organizations called sponsors.
Support includes contributions of facilities, expertise, and/or financial resources.
All sponsors in the database have been assigned one of the following organization types:
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
Study Phase
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Age Group
Studies may be designed for participants of particular ages:
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Gender
Searches can be restricted to studies which accept female or male participants.
Location Terms
If you are interested in a specific city (such as Los Angeles) or facility
name (such as the Mayo Clinic), enter it as a location term. Not all studies
include this level of detail, but if they do, this will find them.
Countries and States
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state.
Study IDs
Each trial is assigned one or more identification numbers by the institute, agency,
or organization sponsoring the trial. In addition, clinical trials assigns a
unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit.
Use this box to search for a trial by NCT identifier or any other study
identification numbers.
Examples:
Examples:
NCT00001789
97-h-0197
ia0006
actg 076
97-h-0197
ia0006
actg 076
Sponsor (Lead)
Use this box to specify the name of an institute, organization, or company that is
conducting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators
Use this box to specify institutes, organizations, or companies that are
conducting or otherwise supporting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Outcome Measures
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Outcome measures are used to evaluate trial results. For example, an obesity treatment
might be evaluated by a measure of weight loss after 6 months. Measures can also be used
to quantify side effects, such as number of myocardial infarctions,
number of patients with heart arrhythmia, number of suicides, etc.
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Interventions
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Conditions
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Study Type
There are three types of studies available in ClinicalTrials.gov:
There are three types of studies available in ClinicalTrials.gov:
Interventional:
Observational:
Expanded Access:
Studies where individuals are assigned to receive specific interventions.
Participants may receive diagnostic, therapeutic or other types of interventions.
Assignment of the intervention may or may not be random.
Individuals are tracked and biomedical and/or health outcomes are assessed.
Observational:
Studies without an intervention.
Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals.
Participants may receive diagnostic, therapeutic, or other interventions, but the investigator
does not assign specific interventions to the participants of the study.
Expanded Access:
Records describing the procedure for obtaining an experimental drug or device for patients who
are failing on currently available treatments for their condition and also are unable to
participate in ongoing clinical trials. Expanded Access records are used to register all
types of non-protocol access to experimental treatments, including protocol exception,
single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.
Study Results
Searches can be restricted to studies with or without results.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Recruitment Status
Also known as Enrollment Status.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Search Terms
Use this box to specify general search terms found anywhere in the trial record.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help for Searching clinical trials
Help Topics:
Basic Search:
On the Basic Search page, enter a word or word(s) that you want to use to find studies.
These may include diseases, interventions, and/or locations.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
Many searches are a single term and can be performed with a few words in the
search box. But, sometimes you need more control. Click on the Advanced Search tab
(if starting a new search) or Refine Search tab (if modifying an existing search)
to show additional search fields.
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
Sponsor (Lead):
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Performs a general search in all sections of the study record, including title,
description, conditions, interventions, locations, etc. Terms in this field are
searched the same as Basic Search.
Recruitment:
Limits search results to studies that are open or closed. New volunteers may be
able to participate in open studies, but not closed studies.
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Study Results:Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Limits search results based on whether the study has results or not:
Study Type:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov.
Only a few studies have results available.Studies With Results, or
Studies Without Results
Limits search results to any of the following study types:
Conditions:
Interventional,
Observational, or
Expanded Access
Observational, or
Expanded Access
Performs a search on fields describing the diseases or conditions being studied.
Interventions:
Performs a search on fields listing the drugs or interventions being studied.
Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.
Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
Performs a search on the sponsor field of a study.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Performs a search on fields listing ID numbers.
Country/State:
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state (e.g., United States, Alabama).
Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic).
Not all studies include this level of detail, but if they do, this will find them.
Gender:
Limits search results to those studies that accept female or male participants.
Age Group:
Limits search results to those studies that include at least one of the specified age
ranges. More than one age group can be selected.
Phase:
Limits search results to studies that are labeled with at least one of the specified
phases. More than one Phase can be selected.
Funded By:
Limits search results to studies that have at least one sponsor of the specified types.
More than one sponsor type can be selected.
Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.
First Received:
Limits search results to studies that were received by clinical trials within a
specified date range. The "From" or "To" field can be left blank.
Last Updated:
Limits search results to studies that were modified within a
specified date range. The "From" or "To" field can be left blank.
Refine Search:
Searches display a list of studies found (List Results tab). If you are not content with
the search results, click on the Refine Search tab at the top of the list to modify your
search.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
When you are done making changes, click Search to display the new results.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.